MA (EU) number 
(Invented) 
name 
Strength  Pharmaceutical Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/23/1736/001  Omvoh   
300 mg 
EU/1/23/1736/002  Omvoh   
100 mg 
Concentrate for solution 
for infusion 
Solution for injection 
Subcutaneous use 
Intravenous use 
vial (glass) 
15 ml (20 mg/ml) 
1 vial  
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) in pre-filled 
pen 
pre-filled syringe 
(glass) in pre-filled 
pen 
pre-filled syringe 
(glass) in pre-filled 
pen 
1 ml (100 mg/ml) 
2 pre-filled syringes  
1 ml (100 mg/ml) 
1 ml (100 mg/ml) 
1 ml (100 mg/ml) 
1 ml (100 mg/ml) 
6 (3 x 2) pre-filled 
syringes 
(multipack)  
2 pre-filled pens  
4 (2 x 2) pre-filled 
pens (multipack)  
6 (3 x 2) pre-filled 
pens (multipack)  
EU/1/23/1736/003  Omvoh   
100 mg 
Solution for injection 
Subcutaneous use 
EU/1/23/1736/004  Omvoh   
100 mg 
Solution for injection 
Subcutaneous use 
EU/1/23/1736/005  Omvoh   
100 mg 
Solution for injection 
Subcutaneous use 
EU/1/23/1736/006  Omvoh   
100 mg 
Solution for injection 
Subcutaneous use 
1/1 
 
 
 
 
